Intraoperative magnesium infusion during carotid endarterectomy: A double-blind placebo-controlled trial: Clinical article

William J. Mack, Christopher P. Kellner, Daniel H. Sahlein, Andrew F. Ducruet, Grace H. Kim, J. Mocco, Joseph Zurica, Ricardo J Komotar, Raqeeb Haque, Robert Sciacca, Donald O. Quest, Robert A. Solomon, E. Sander Connolly, Eric J. Heyer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Object. Recent data from both experimental and clinical studies have supported the use of intravenous magnesium as a potential therapy in the setting of cerebral ischemia. This study assessed whether intraoperative magnesium therapy improves neuropsychometric testing (NPT) following carotid endarterectomy (CEA). Methods. One hundred eight patients undergoing CEA were randomly assigned to receive placebo infusion or 1 of 3 magnesium-dosing protocols. Neuropsychometric testing was performed 1 day after surgery and compared with baseline performance. Assessment was also performed on a set of 35 patients concurrently undergoing lumbar laminectomy to serve as a control group for NPT. A forward stepwise logistic regression analysis was performed to evaluate the impact of magnesium therapy on NPT. A subgroup analysis was then performed, analyzing the impact of each intraoperative dose on NPT. Results. Patients treated with intravenous magnesium infusion demonstrated less postoperative neurocognitive impairment than those treated with placebo (OR 0.27, 95% CI 0.10-0.74, p = 0.01). When stratified according to dosing bolus and intraoperative magnesium level, those who were treated with low-dose magnesium had less cognitive decline than those treated with placebo (OR 0.09, 95% CI 0.02-0.50, p < 0.01). Those in the high-dose magnesium group demonstrated no difference from the placebo-treated group. Conclusions. Low-dose intraoperative magnesium therapy protects against neurocognitive decline following CEA.

Original languageEnglish
Pages (from-to)961-967
Number of pages7
JournalJournal of Neurosurgery
Volume110
Issue number5
DOIs
StatePublished - May 1 2009
Externally publishedYes

Fingerprint

Carotid Endarterectomy
Controlled Clinical Trials
Magnesium
Placebos
Laminectomy
Therapeutics
Brain Ischemia
Ambulatory Surgical Procedures
Intravenous Infusions
Logistic Models
Regression Analysis
Control Groups

Keywords

  • Carotid endarterectomy
  • Magnesium
  • Neuroprotectant
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Mack, W. J., Kellner, C. P., Sahlein, D. H., Ducruet, A. F., Kim, G. H., Mocco, J., ... Heyer, E. J. (2009). Intraoperative magnesium infusion during carotid endarterectomy: A double-blind placebo-controlled trial: Clinical article. Journal of Neurosurgery, 110(5), 961-967. https://doi.org/10.3171/2008.9.17671

Intraoperative magnesium infusion during carotid endarterectomy : A double-blind placebo-controlled trial: Clinical article. / Mack, William J.; Kellner, Christopher P.; Sahlein, Daniel H.; Ducruet, Andrew F.; Kim, Grace H.; Mocco, J.; Zurica, Joseph; Komotar, Ricardo J; Haque, Raqeeb; Sciacca, Robert; Quest, Donald O.; Solomon, Robert A.; Connolly, E. Sander; Heyer, Eric J.

In: Journal of Neurosurgery, Vol. 110, No. 5, 01.05.2009, p. 961-967.

Research output: Contribution to journalArticle

Mack, WJ, Kellner, CP, Sahlein, DH, Ducruet, AF, Kim, GH, Mocco, J, Zurica, J, Komotar, RJ, Haque, R, Sciacca, R, Quest, DO, Solomon, RA, Connolly, ES & Heyer, EJ 2009, 'Intraoperative magnesium infusion during carotid endarterectomy: A double-blind placebo-controlled trial: Clinical article', Journal of Neurosurgery, vol. 110, no. 5, pp. 961-967. https://doi.org/10.3171/2008.9.17671
Mack, William J. ; Kellner, Christopher P. ; Sahlein, Daniel H. ; Ducruet, Andrew F. ; Kim, Grace H. ; Mocco, J. ; Zurica, Joseph ; Komotar, Ricardo J ; Haque, Raqeeb ; Sciacca, Robert ; Quest, Donald O. ; Solomon, Robert A. ; Connolly, E. Sander ; Heyer, Eric J. / Intraoperative magnesium infusion during carotid endarterectomy : A double-blind placebo-controlled trial: Clinical article. In: Journal of Neurosurgery. 2009 ; Vol. 110, No. 5. pp. 961-967.
@article{84f88bd7378c4fd1a625656da228c8f0,
title = "Intraoperative magnesium infusion during carotid endarterectomy: A double-blind placebo-controlled trial: Clinical article",
abstract = "Object. Recent data from both experimental and clinical studies have supported the use of intravenous magnesium as a potential therapy in the setting of cerebral ischemia. This study assessed whether intraoperative magnesium therapy improves neuropsychometric testing (NPT) following carotid endarterectomy (CEA). Methods. One hundred eight patients undergoing CEA were randomly assigned to receive placebo infusion or 1 of 3 magnesium-dosing protocols. Neuropsychometric testing was performed 1 day after surgery and compared with baseline performance. Assessment was also performed on a set of 35 patients concurrently undergoing lumbar laminectomy to serve as a control group for NPT. A forward stepwise logistic regression analysis was performed to evaluate the impact of magnesium therapy on NPT. A subgroup analysis was then performed, analyzing the impact of each intraoperative dose on NPT. Results. Patients treated with intravenous magnesium infusion demonstrated less postoperative neurocognitive impairment than those treated with placebo (OR 0.27, 95{\%} CI 0.10-0.74, p = 0.01). When stratified according to dosing bolus and intraoperative magnesium level, those who were treated with low-dose magnesium had less cognitive decline than those treated with placebo (OR 0.09, 95{\%} CI 0.02-0.50, p < 0.01). Those in the high-dose magnesium group demonstrated no difference from the placebo-treated group. Conclusions. Low-dose intraoperative magnesium therapy protects against neurocognitive decline following CEA.",
keywords = "Carotid endarterectomy, Magnesium, Neuroprotectant, Stroke",
author = "Mack, {William J.} and Kellner, {Christopher P.} and Sahlein, {Daniel H.} and Ducruet, {Andrew F.} and Kim, {Grace H.} and J. Mocco and Joseph Zurica and Komotar, {Ricardo J} and Raqeeb Haque and Robert Sciacca and Quest, {Donald O.} and Solomon, {Robert A.} and Connolly, {E. Sander} and Heyer, {Eric J.}",
year = "2009",
month = "5",
day = "1",
doi = "10.3171/2008.9.17671",
language = "English",
volume = "110",
pages = "961--967",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Intraoperative magnesium infusion during carotid endarterectomy

T2 - A double-blind placebo-controlled trial: Clinical article

AU - Mack, William J.

AU - Kellner, Christopher P.

AU - Sahlein, Daniel H.

AU - Ducruet, Andrew F.

AU - Kim, Grace H.

AU - Mocco, J.

AU - Zurica, Joseph

AU - Komotar, Ricardo J

AU - Haque, Raqeeb

AU - Sciacca, Robert

AU - Quest, Donald O.

AU - Solomon, Robert A.

AU - Connolly, E. Sander

AU - Heyer, Eric J.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Object. Recent data from both experimental and clinical studies have supported the use of intravenous magnesium as a potential therapy in the setting of cerebral ischemia. This study assessed whether intraoperative magnesium therapy improves neuropsychometric testing (NPT) following carotid endarterectomy (CEA). Methods. One hundred eight patients undergoing CEA were randomly assigned to receive placebo infusion or 1 of 3 magnesium-dosing protocols. Neuropsychometric testing was performed 1 day after surgery and compared with baseline performance. Assessment was also performed on a set of 35 patients concurrently undergoing lumbar laminectomy to serve as a control group for NPT. A forward stepwise logistic regression analysis was performed to evaluate the impact of magnesium therapy on NPT. A subgroup analysis was then performed, analyzing the impact of each intraoperative dose on NPT. Results. Patients treated with intravenous magnesium infusion demonstrated less postoperative neurocognitive impairment than those treated with placebo (OR 0.27, 95% CI 0.10-0.74, p = 0.01). When stratified according to dosing bolus and intraoperative magnesium level, those who were treated with low-dose magnesium had less cognitive decline than those treated with placebo (OR 0.09, 95% CI 0.02-0.50, p < 0.01). Those in the high-dose magnesium group demonstrated no difference from the placebo-treated group. Conclusions. Low-dose intraoperative magnesium therapy protects against neurocognitive decline following CEA.

AB - Object. Recent data from both experimental and clinical studies have supported the use of intravenous magnesium as a potential therapy in the setting of cerebral ischemia. This study assessed whether intraoperative magnesium therapy improves neuropsychometric testing (NPT) following carotid endarterectomy (CEA). Methods. One hundred eight patients undergoing CEA were randomly assigned to receive placebo infusion or 1 of 3 magnesium-dosing protocols. Neuropsychometric testing was performed 1 day after surgery and compared with baseline performance. Assessment was also performed on a set of 35 patients concurrently undergoing lumbar laminectomy to serve as a control group for NPT. A forward stepwise logistic regression analysis was performed to evaluate the impact of magnesium therapy on NPT. A subgroup analysis was then performed, analyzing the impact of each intraoperative dose on NPT. Results. Patients treated with intravenous magnesium infusion demonstrated less postoperative neurocognitive impairment than those treated with placebo (OR 0.27, 95% CI 0.10-0.74, p = 0.01). When stratified according to dosing bolus and intraoperative magnesium level, those who were treated with low-dose magnesium had less cognitive decline than those treated with placebo (OR 0.09, 95% CI 0.02-0.50, p < 0.01). Those in the high-dose magnesium group demonstrated no difference from the placebo-treated group. Conclusions. Low-dose intraoperative magnesium therapy protects against neurocognitive decline following CEA.

KW - Carotid endarterectomy

KW - Magnesium

KW - Neuroprotectant

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=66849129541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66849129541&partnerID=8YFLogxK

U2 - 10.3171/2008.9.17671

DO - 10.3171/2008.9.17671

M3 - Article

C2 - 19199498

AN - SCOPUS:66849129541

VL - 110

SP - 961

EP - 967

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 5

ER -